Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.760
+0.090 (5.39%)
At close: Jun 12, 2026, 4:00 PM EDT
1.740
-0.020 (-1.14%)
After-hours: Jun 12, 2026, 5:27 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $111.51 million as of June 12, 2026. Its market cap has increased by 44.00% in one year.
Market Cap
111.51M
Enterprise Value
88.74M
1-Year Change
44.00%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $111.51M, a decrease of -78.71%. That is a compound annual growth rate of -28.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 111.51M | 55.73% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 120.61M |
| NeOnc Technologies Holdings | 120.25M |
| Jyong Biotech | 117.29M |
| Polaryx Therapeutics | 112.20M |
| Coya Therapeutics | 111.19M |
| enGene Therapeutics | 108.52M |
| Cognition Therapeutics | 108.12M |
| Aldeyra Therapeutics | 106.17M |